论文部分内容阅读
本文收集粤苏浙鲁中药上市公司财务数据,应用熵值法对样本企业可持续增长能力进行九年追踪研究,得出以下结论:1我国中药企业规模快速增长的同时,可持续增长能力并未有效提升;2不同企业之间盈利能力均质化特征比较明显,企业未能通过优势产品形成可持续增长的竞争优势;3运营能力是体现我国中药企业可持续增长能力的首要指标;4宏观经济环境是影响中药企业发展的重要因素,地方政府激励政策可以在一定程度上促进中药企业可持续增长能力的提升;5《中医药发展战略规划纲要(2016—2030年)》有益于提升中药企业可持续增长能力,执行过程中,对鼓励创新和质量标准体系完善应该给予特别关注。
This paper collects the financial data of Guangdong, Zhejiang, Shandong and Shandong traditional Chinese medicine listed companies, and uses entropy method to conduct a nine-year follow-up study on the sustainable growth ability of sample companies. The conclusions are as follows: 1 While the rapid growth of TCM enterprises in China, Effectively enhance the 2 homogeneity of profitability between different enterprises more obvious characteristics, enterprises can not form a competitive advantage of sustainable growth; 3 operational capacity is to reflect the capacity of Chinese medicine enterprises in the primary indicators of sustainable growth; 4 macroeconomic The environment is an important factor that affects the development of Chinese medicine enterprises. Local government incentives can promote the enhancement of the sustainable growth capability of Chinese medicine enterprises to a certain extent. 5 The Strategic Plan for the Development of Chinese Medicine (2016-2030) The ability to continue to grow, the implementation process, to encourage innovation and improve the quality standard system should pay special attention.